CoChat

Glucagon-like Peptide-1 Receptor in the Human Hypothalamus Is Associated with Body Mass Index and Colocalizes with the Anorexigenic Neuropeptide Nucleobindin-2/Nesfatin-1

Open access

Published version of a preprint

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

Data on animals emphasize the importance of the neuronal glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) for feeding suppression, although it is unclear whether astrocytes participate in the transduction of anorectic GLP-1R-dependent signals. In humans, the brain circuitry underlying these effects remains insufficiently investigated. The present study aimed to explore GLP-1R protein expression in the human hypothalamus and its correlation with body mass index (BMI). Sections of hypothalamus from 28 autopsy cases, 11 with normal weight (BMI < 25 kg/m2) and 17 with non-normal weight (BMI ≥ 25 kg/m2), were examined using immunohistochemistry and double immunofluorescence labeling. Prominent GLP-1R immunoexpression was detected in neurons of several hypothalamic nuclei, including paraventricular, supraoptic, and infundibular nuclei; the lateral hypothalamic area (LH); and basal forebrain nuclei. Interestingly, in the LH, GLP-1R was significantly decreased in individuals with BMI ≥ 25 kg/m2 compared with their normal weight counterparts (p = 0.03). Furthermore, GLP-1R was negatively correlated (τb = −0.347, p = 0.024) with BMI levels only in the LH. GLP-1R extensively colocalized with the anorexigenic and antiobesogenic neuropeptide nucleobindin-2/nesfatin-1 but not with the astrocytic marker glial fibrillary acidic protein. These data suggest a potential role for GLP-1R in the regulation of energy balance in the human hypothalamus. In the LH, an appetite- and reward-related brain region, reduced GLP-1R immunoexpression may contribute to the dysregulation of homeostatic and/or hedonic feeding behavior. Possible effects of NUCB2/nesfatin-1 on central GLP-1R signaling require further investigation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms232314899

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Representative sections of human hypothalamus showing GLP-1R immunoexpression in neurons of the paraventricular nucleus (a), supraoptic nucleus (b), infundibular nucleus (c), lateral hypothalamic area (d), dorsomedial nucleus (e), basal nucleus (f), diagonal band (g). The 3V, third ventricle; fx, fornix; opt, optic tract. Scale bars indicate 100 μm (a–c) and 200 μm (d–g).
Figure 1 Representative sections of human hypothalamus showing GLP-1R immunoexpression in neurons of the paraventricular nucleus (a), supraoptic nucleus (b), infundibular nucleus (c), lateral hypothalamic area (d), dorsomedial nucleus (e), basal nucleus (f), diagonal band (g). The 3V, third ventricle; fx, fornix; opt, optic tract. Scale bars indicate 100 μm (a–c) and 200 μm (d–g).CC BY · PubMed Central
Figure 2 Schematic illustration of GLP-1R distribution in the human hypothalamus. Depiction of GLP-1R-ir cell bodies (blue dots) and GLP-1R-ir fibers (red lines) in four representative coronal sections of human hypothalamus (a–d) arranged from rostral (a) to caudal (d). Dark blue coloring indicates areas showing high staining intensity for GLP-1R and light blue indicates less intense staining. The 3V, third ventricle; ac, anterior commissure; al, ansa lenticularis; BN, basal nucleus; BST, bed nucleus of the stria terminalis; cp, cerebral peduncle; DB, diagonal band; DMH, dorsomedial hypothalamic nucleus; fx, fornix; h2, lenticular fascicle; ic, internal capsule; IFN, infundibular nucleus; InfS, infundibular stalk; LH, lateral hypothalamic area; mfb, medial forebrain bundle; mfb, medial forebrain bundle; MN, mammillary nucleus; MPO, medial preoptic nucleus; opt, optic tract; ox, optic chiasm; PalHy, pallidohypothalamic nucleus; Pe, periventricular nucleus; PeF, perifornical nucleus; PH, posterior hypothalamic area; prf, principal fasciculus; PVN, paraventricular nucleus; SCh, suprachiasmatic nucleus; SON, supraoptic nucleus; SODL, supraoptic nucleus (dorsolateral part); SOVM, supraoptic nucleus (ventromedial part); sox, supraoptic commissure; SuM, supramammillary nucleus; TM, tuberomammillary nucleus; VMH; ventromedial hypothalamic nucleus; ZI, zona incerta.
Figure 2 Schematic illustration of GLP-1R distribution in the human hypothalamus. Depiction of GLP-1R-ir cell bodies (blue dots) and GLP-1R-ir fibers (red lines) in four representative coronal sections of human hypothalamus (a–d) arranged from rostral (a) to caudal (d). Dark blue coloring indicates areas showing high staining intensity for GLP-1R and light blue indicates less intense staining. The 3V, third ventricle; ac, anterior commissure; al, ansa lenticularis; BN, basal nucleus; BST, bed nucleus of the stria terminalis; cp, cerebral peduncle; DB, diagonal band; DMH, dorsomedial hypothalamic nucleus; fx, fornix; h2, lenticular fascicle; ic, internal capsule; IFN, infundibular nucleus; InfS, infundibular stalk; LH, lateral hypothalamic area; mfb, medial forebrain bundle; mfb, medial forebrain bundle; MN, mammillary nucleus; MPO, medial preoptic nucleus; opt, optic tract; ox, optic chiasm; PalHy, pallidohypothalamic nucleus; Pe, periventricular nucleus; PeF, perifornical nucleus; PH, posterior hypothalamic area; prf, principal fasciculus; PVN, paraventricular nucleus; SCh, suprachiasmatic nucleus; SON, supraoptic nucleus; SODL, supraoptic nucleus (dorsolateral part); SOVM, supraoptic nucleus (ventromedial part); sox, supraoptic commissure; SuM, supramammillary nucleus; TM, tuberomammillary nucleus; VMH; ventromedial hypothalamic nucleus; ZI, zona incerta.CC BY · PubMed Central
Figure 3 Comparison of GLP-1R immunoexpression in lateral hypothalamic area from a normal weight and a non-normal weight individual, both with similar clinicopathological characteristics. Images taken in similar rostrocaudal levels (medial zone of the tuberal region) are derived from a male with BMI 23.0 kg/m2, displaying high GLP-1R immunoreactivity, (a) and a male with BMI 46.3 kg/m2, showing low GLP-1R immunoreactivity (b). Bar denotes 200 µm.
Figure 3 Comparison of GLP-1R immunoexpression in lateral hypothalamic area from a normal weight and a non-normal weight individual, both with similar clinicopathological characteristics. Images taken in similar rostrocaudal levels (medial zone of the tuberal region) are derived from a male with BMI 23.0 kg/m2, displaying high GLP-1R immunoreactivity, (a) and a male with BMI 46.3 kg/m2, showing low GLP-1R immunoreactivity (b). Bar denotes 200 µm.CC BY · PubMed Central
Figure 4 Representative light microscopic fluorescent images depicting GLP-1R and NUCB2/nesfatin-1 colocalization in the human hypothalamus. Representative sections of paraventricular nucleus (a–c), supraoptic nucleus (d–f), infundibular nucleus (g–i), lateral hypothalamic area (g–l), and basal nucleus (m–o) double stained for GLP-1R (green) and NUCB2/nesfatin-1 (red). Merged images depict double stained neurons (c,f,i,l,o) (200×). Insets represent neurons at higher magnification (400×). fx, fornix; opt, optic tract. Scale bars indicate 50 μm.
Figure 4 Representative light microscopic fluorescent images depicting GLP-1R and NUCB2/nesfatin-1 colocalization in the human hypothalamus. Representative sections of paraventricular nucleus (a–c), supraoptic nucleus (d–f), infundibular nucleus (g–i), lateral hypothalamic area (g–l), and basal nucleus (m–o) double stained for GLP-1R (green) and NUCB2/nesfatin-1 (red). Merged images depict double stained neurons (c,f,i,l,o) (200×). Insets represent neurons at higher magnification (400×). fx, fornix; opt, optic tract. Scale bars indicate 50 μm.CC BY · PubMed Central
Figure 5 Confocal image showing GLP-1R and GFAP double immunofluorescence labeling in human hypothalamus. Panel (a) shows GLP-1R-immunoreactivity (green) and panel (b) displays GFAP-immunoreactivity (red). The merged image (c) shows the lack of colocalization of GLP-1R and GFAP. Scale bar equals 50 μm (25 μm in insets).
Figure 5 Confocal image showing GLP-1R and GFAP double immunofluorescence labeling in human hypothalamus. Panel (a) shows GLP-1R-immunoreactivity (green) and panel (b) displays GFAP-immunoreactivity (red). The merged image (c) shows the lack of colocalization of GLP-1R and GFAP. Scale bar equals 50 μm (25 μm in insets).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 52 references

Research works printed but not linked: 2

  1. Swaab D.F. Part I: Nuclei of the human hypothalamus: Cytoarchitecture, chemoarchitecture, functional neuroanatomy, topographic neuropathology Handbook of Clinical Neurology. The Human Hypothalamus: Basic and Clinical Aspects Aminoff M.J. Boller F. Swaab D.F. Elsevier Amsterdam, The Netherlands 2003 Volume 79 3 59
  2. Mai J. Majtanik M. Paxinos G. Part 2: Myelo- and cytoarchitectonic atlas of the human brain in stereotaxic (MNI) space Atlas of the Human Brain 4th ed. Mai J. Majtanik M. Paxinos G. Academic Press Cambridge, MA, USA Elsevier Amsterdam, The Netherlands 2015 181–233, 427–431

Cited by

See all 25

Metadata

Authors
Psilopanagioti, A., Nikou, S., Logotheti, S., Arbi, M., Chartoumpekis, D. V., & Papadaki, H.
Affiliations
  • University of Patras (GR)
  • Centre Hospitalier Universitaire Vaudois (CH)
Corresponding author
Psilopanagioti, Aristea
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2022-11-28
Volume
23
Issue
23
Pages
14899
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4310154266
Cited by
22
References
52
Citations by year
2026: 10 · 2025: 4 · 2024: 6 · 2023: 2
FWCI
1.58
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Patras
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
GLP-1 receptor, hypothalamus, NUCB2, nesfatin-1, lateral hypothalamus, body mass index, obesity, energy balance, appetite regulation, feeding behavior, neuropeptide co-localization, astrocytes, glial fibrillary acidic protein
MeSH terms
Glucagon-Like Peptide-1 Receptor, Animals, Arcuate Nucleus of Hypothalamus, Humans, Hypothalamus, Neuropeptides, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.